title: Functional analysis in mouse embryonic stem cells reveals wild-type activity for three MSH6 variants found in suspected Lynch syndrome patients.
abstract: Lynch syndrome confers an increased risk to various types of cancer, in particular early onset colorectal and endometrial cancer. Mutations in mismatch repair (MMR) genes underlie Lynch syndrome, with the majority of mutations found in MLH1 and MSH2. Mutations in MSH6 have also been found but these do not always cause a clear cancer predisposition phenotype and MSH6-defective tumors often do not show the standard characteristics of MMR deficiency, such as microsatellite instability. In particular, the consequences of MSH6 missense mutations are challenging to predict, which further complicates genetic counseling. We have previously developed a method for functional characterization of MSH2 missense mutations of unknown significance. This method is based on endogenous gene modification in mouse embryonic stem cells using oligonucleotide-directed gene targeting, followed by a series of functional assays addressing the MMR functions. Here we have adapted this method for the characterization of MSH6 missense mutations. We recreated three MSH6 variants found in suspected Lynch syndrome families, MSH6-P1087R, MSH6-R1095H and MSH6-L1354Q, and found all three to behave like wild type MSH6. Thus, despite suspicion for pathogenicity from clinical observations, our approach indicates these variants are not disease causing. This has important implications for counseling of mutation carriers.
authors.affiliation: Division of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
authors.forename: Eva A L
authors.initials: EA
authors.lastname: Wielders
authors.forename: Hellen
authors.initials: H
authors.lastname: Houlleberghs
authors.forename: Gözde
authors.initials: G
authors.lastname: Isik
authors.forename: Hein
authors.initials: H
authors.lastname: te Riele
mesh_terms: D000483:Alleles; D000818:Animals; D003062:Codon; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000235:genetics*; D053843:DNA Mismatch Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D053595:Embryonic Stem Cells / Q000166:cytology*; D006579:Heterozygote; D006801:Humans; D051379:Mice; D053842:Microsatellite Instability; D018895:Microsatellite Repeats / Q000235:genetics; D051718:MutS Homolog 2 Protein / Q000235:genetics; D020125:Mutation, Missense; D010641:Phenotype; D011995:Recombination, Genetic
chemical_list: D003062:Codon; D004268:DNA-Binding Proteins; C094443:G-T mismatch-binding protein; C102997:Msh6 protein, mouse; C497172:MSH2 protein, human; C497173:Msh2 protein, mouse; D051718:MutS Homolog 2 Protein
references.citation: JAMA. 2006 Sep 27;296(12):1507-17
references.pmid: 17003399
references.citation: Oncogene. 2007 Apr 12;26(17):2513-7
references.pmid: 17043646
references.citation: J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
references.pmid: 14970275
references.citation: J Biomed Sci. 2009 Apr 24;16:42
references.pmid: 19389263
references.citation: J Clin Oncol. 2004 Nov 15;22(22):4486-94
references.pmid: 15483016
references.citation: Nat Rev Mol Cell Biol. 2006 May;7(5):335-46
references.pmid: 16612326
references.citation: J Med Genet. 1999 Nov;36(11):801-18
references.pmid: 10544223
references.citation: Mol Cell Biol. 1992 May;12(5):2391-5
references.pmid: 1569957
references.citation: Nat Genet. 1999 Oct;23(2):142-4
references.pmid: 10508506
references.citation: Hum Mol Genet. 2002 May 15;11(11):1303-10
references.pmid: 12019211
references.citation: J Natl Cancer Inst. 2010 Feb 3;102(3):193-201
references.pmid: 20028993
references.citation: Hum Mutat. 2011 Apr;32(4):389-96
references.pmid: 21309037
references.citation: Hum Mutat. 2011 May;32(5):557-63
references.pmid: 21520333
references.citation: Mol Carcinog. 2005 Dec;44(4):285-92
references.pmid: 16240453
references.citation: Oncogene. 2002 Oct 24;21(49):7585-92
references.pmid: 12386821
references.citation: Cell. 1995 Jul 28;82(2):321-30
references.pmid: 7628020
references.citation: Br J Cancer. 2010 Dec 7;103(12):1840-5
references.pmid: 21081928
references.citation: Am J Hum Genet. 1999 Nov;65(5):1291-8
references.pmid: 10521294
references.citation: Hum Genet. 2003 Feb;112(2):105-9
references.pmid: 12522549
references.citation: Hum Mutat. 2008 Jun;29(6):852-60
references.pmid: 18383312
references.citation: Nat Genet. 1999 Nov;23(3):359-62
references.pmid: 10545954
references.citation: Cancer Res. 1999 Oct 15;59(20):5068-74
references.pmid: 10537275
references.citation: Cancer Res. 1998 Jan 15;58(2):248-55
references.pmid: 9443401
references.citation: Nature. 1990 Dec 13;348(6302):649-51
references.pmid: 2250720
references.citation: Nucleic Acids Res. 2006;34(21):e147
references.pmid: 17142234
references.citation: Clin Cancer Res. 2010 Nov 15;16(22):5402-13
references.pmid: 20924129
references.citation: Nature. 1987 Mar 19-25;326(6110):292-5
references.pmid: 3821905
references.citation: Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6853-61
references.pmid: 16203774
references.citation: Nat Genet. 1994 Dec;8(4):405-10
references.pmid: 7894494
references.citation: Hum Mutat. 2012 Mar;33(3):488-94
references.pmid: 22102614
references.citation: Hum Genet. 2006 Mar;119(1-2):206-11
references.pmid: 16408224
references.citation: Br J Cancer. 2010 Mar 16;102(6):1068-73
references.pmid: 20160730
references.citation: Mol Cell Biol. 1998 Nov;18(11):6616-23
references.pmid: 9774676
references.citation: Hum Mutat. 2011 Jan;32(1):107-15
references.pmid: 21120944
references.citation: Hum Mutat. 2007 Nov;28(11):1047-54
references.pmid: 17594722
references.citation: Oncogene. 2002 Apr 25;21(18):2873-9
references.pmid: 11973647
references.citation: Oncogene. 2005 Jun 2;24(24):3995-8
references.pmid: 15782118
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5128-32
references.pmid: 1594621
references.citation: Nat Genet. 2009 Jan;41(1):112-7
references.pmid: 19098912